Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BOLT CVE:CZX CVE:GRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOLTBolt Biotherapeutics$4.22-0.9%$4.74$3.75▼$7.20$8.20M1.1230,995 shs6,771 shsCZXCanada Zinc MetalsC$0.31+∞C$0.31C$0.22▼C$0.39C$51.69MN/A238,645 shs118,500 shsGRRGolden Reign ResourcesC$0.20+5.3%C$0.20C$0.15▼C$0.30C$38.43MN/A131,149 shs684,600 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOLTBolt Biotherapeutics-0.94%+0.24%-14.75%-6.22%-24.51%CZXCanada Zinc Metals0.00%0.00%0.00%0.00%0.00%GRRGolden Reign Resources0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOLTBolt Biotherapeutics$4.22-0.9%$4.74$3.75▼$7.20$8.20M1.1230,995 shs6,771 shsCZXCanada Zinc MetalsC$0.31+∞C$0.31C$0.22▼C$0.39C$51.69MN/A238,645 shs118,500 shsGRRGolden Reign ResourcesC$0.20+5.3%C$0.20C$0.15▼C$0.30C$38.43MN/A131,149 shs684,600 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOLTBolt Biotherapeutics-0.94%+0.24%-14.75%-6.22%-24.51%CZXCanada Zinc Metals0.00%0.00%0.00%0.00%0.00%GRRGolden Reign Resources0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBOLTBolt Biotherapeutics 2.40Hold$34.67721.48% UpsideCZXCanada Zinc Metals 0.00N/AN/AN/AGRRGolden Reign Resources 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest GRR, BOLT, and CZX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2026BOLTBolt Biotherapeutics Rodman & RenshawSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$22.005/28/2026BOLTBolt Biotherapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$7.004/20/2026BOLTBolt Biotherapeutics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBOLTBolt Biotherapeutics$7.70M1.05N/AN/A$13.81 per share0.31CZXCanada Zinc MetalsN/AN/AN/AN/AN/AN/AGRRGolden Reign ResourcesN/AN/AC$0.02 per share9.52C$0.20 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBOLTBolt Biotherapeutics-$33.38M-$16.33N/AN/AN/A-455.15%-100.89%-48.23%8/13/2026 (Estimated)CZXCanada Zinc MetalsN/AN/AN/AN/AN/AN/AN/AN/AN/AGRRGolden Reign ResourcesN/A-C$0.01N/AN/AN/AN/AN/AN/AN/ALatest GRR, BOLT, and CZX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026BOLTBolt Biotherapeutics-$2.85-$4.31-$1.46-$4.31$1.50 million$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBOLTBolt BiotherapeuticsN/AN/AN/AN/AN/ACZXCanada Zinc MetalsN/AN/AN/AN/AN/AGRRGolden Reign ResourcesC$0.0735.00%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBOLTBolt Biotherapeutics0.983.513.51CZXCanada Zinc MetalsN/AN/AN/AGRRGolden Reign Resources10.310.690.68Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBOLTBolt Biotherapeutics86.70%CZXCanada Zinc MetalsN/AGRRGolden Reign ResourcesN/AInsider OwnershipCompanyInsider OwnershipBOLTBolt Biotherapeutics9.40%CZXCanada Zinc MetalsN/AGRRGolden Reign ResourcesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBOLTBolt Biotherapeutics901.92 million1.74 millionNot OptionableCZXCanada Zinc Metals147,000166.73 millionN/ANot OptionableGRRGolden Reign ResourcesN/A192.17 millionN/ANot OptionableGRR, BOLT, and CZX HeadlinesRecent News About These CompaniesGolden Retriever Obsessed With Watching Cooking Shows Delights InternetMay 22, 2024 | newsweek.comNGrange Resources Ltd (GRR.HM)April 17, 2024 | finance.yahoo.comGrange Resources Ltd.February 21, 2024 | wsj.comGrange Resources Ltd GRRDecember 8, 2023 | morningstar.comMReign and Rapinoe, Gotham and Krieger advance to NWSL championship game before retiringNovember 6, 2023 | cbs17.comCMako Mining Corp (MKO)September 19, 2023 | investing.comGolden Ridge Resources Ltd (GLDN)July 27, 2023 | investing.comGSRI.CN - Golden Shield Resources Inc.July 23, 2023 | ca.finance.yahoo.comGolden Resources Development International Ltd (0677)May 15, 2023 | investing.comGolden Spike Resources Corp.: Golden Spike Engages SmallCap Communications Inc.May 5, 2023 | finanznachrichten.deGolden Shield Resources closes C$4.6M financingApril 20, 2023 | proactiveinvestors.co.ukShould I Let My Golden Retriever Sleep With Me?February 19, 2023 | msn.comMore than a thousand golden retrievers gathered for a celebration in Golden, ColoradoFebruary 8, 2023 | wmar2news.comWGolden Retriever vs Cherry Tomato Leaves Internet in Stitches: 'Drama'January 22, 2023 | newsweek.comNGolden JellyfishNovember 5, 2022 | nationalgeographic.comN2 The Rescue: Meet DieselOctober 19, 2022 | wfmynews2.comWGolden Reign Resources Ltd. (GRR.V)September 13, 2022 | ca.finance.yahoo.comGolden Resources Development International LtdSeptember 8, 2022 | reuters.comGolden Retriever Rescue Resource hopes to end backyard breedingAugust 25, 2022 | wtol.comWDiggers and Dealers: 130 years on and Northern Star sees more ahead for Golden Mile; Goldies face music on takeover talkAugust 2, 2022 | stockhead.com.auSMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20265 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026Marvell’s Pullback May Be the Setup Bulls Were Waiting ForBy Thomas Hughes | May 29, 2026Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNowBy Thomas Hughes | June 3, 2026Semtech’s Explosive Rally May Only Be Getting StartedBy Thomas Hughes | May 28, 2026GRR, BOLT, and CZX Company DescriptionsBolt Biotherapeutics NASDAQ:BOLT$4.22 -0.04 (-0.94%) Closing price 06/24/2026 04:00 PM EasternExtended Trading$4.16 -0.06 (-1.42%) As of 06/24/2026 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.Canada Zinc Metals CVE:CZXC$0.31 +0.31 (+∞) As of 05/4/2018Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.Golden Reign Resources CVE:GRRC$0.20 +0.01 (+5.26%) As of 11/12/2018Golden Reign Resources Ltd. acquires and explores for mineral properties. The company primarily explores for gold and silver. Its primary exploration and evaluation asset is the San Albino-Murra mining concession located in Nueva Segovia, Nicaragua. The company was incorporated in 2004 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why KB Home Could Reward Patient Investors Later Tesla's New NHTSA Probe Lands at the Worst Possible Time Meta's Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time ASML’s Chip Dominance Runs Into New Silicon Boundaries Frozen Assets: How Super Micro Puts AI Heat on Ice The SpaceX Sell-Off May Be More Than a Market Overreaction Why These South Korea-Focused ETFs Have More Than Doubled in 2026 Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
